Volume 146, Issue 5, Pages (May 2014)

Slides:



Advertisements
Similar presentations
Hepatic Vascular Endothelial Growth Factor Regulates Recruitment of Rat Liver Sinusoidal Endothelial Cell Progenitor Cells Lin Wang, Xiangdong Wang, Lei.
Advertisements

Don C. Rockey  Clinical Gastroenterology and Hepatology 
Cellular and Molecular Mechanisms of Liver Injury
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Lipids in Liver Disease: Looking Beyond Steatosis
Figure 3 Extracellular stimuli to HSC activation
Abhishek Chauhan, David H. Adams  Gastroenterology 
Volume 143, Issue 1, Pages (July 2012)
Obesity Heats Up Adipose Tissue Lymphocytes
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Cellular and Molecular Mechanisms of Liver Injury
Alan N. Houghton, Hiroshi Uchi, Jedd D. Wolchok  Cancer Cell 
Nonalcoholic steatohepatitis
Volume 133, Issue 2, Pages (August 2007)
Roles for Chemokines in Liver Disease
Volume 146, Issue 5, Pages e1 (May 2014)
Senescence: Not Just for Tumor Suppression
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Mechanisms of Hepatic Fibrogenesis
Mechanisms of Obesity-Induced Gastrointestinal Neoplasia
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 134, Issue 5, Pages (May 2008)
Subcapsular Hepatic Dendritic Cells: Hiding in Plain Sight
Volume 141, Issue 6, Pages (December 2011)
Volume 135, Issue 4, Pages (October 2008)
Inflammation and portal hypertension – The undiscovered country
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer  Ilya Gukovsky, Ning Li, Jelena Todoric,
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases  Chien-Wei Lee, Yu-Fan Chen, Hao-Hsiang Wu,
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Nitin Raj, Laura D. Attardi  Current Biology 
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 145, Issue 1, Pages (July 2013)
Viral Hepatitis in Liver Transplantation
Approaches for treatment of liver fibrosis in chronic hepatitis C
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
Obesity, Inflammation, and Insulin Resistance
Hepatic fibrosis: Concept to treatment
YAPping About Glutaminolysis in Hepatic Fibrosis
Covering the Cover Gastroenterology
Braedon McDonald, Paul Kubes  Gastroenterology 
Volume 144, Issue 3, Pages (March 2013)
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer  Thomas Winder, Heinz–Josef.
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Liver fibrosis – from bench to bedside
Antifibrotic therapy in chronic liver disease
Nuclear Factor-κB in the Liver: Friend or Foe?
Diarmaid Dominic Houlihan, Philip Noel Newsome  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
A New Treatment for Portal Hypertension?
The promise of biomarkers for personalized renal cancer care
Volume 141, Issue 1, Pages (July 2011)
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Lipids in Liver Disease: Looking Beyond Steatosis
The Dawning of a New Editorial Board for Gastroenterology
Macrophage heterogeneity in liver injury and fibrosis
“It Is a Good Morning Exercise for a Research Scientist to Discard a Pet Hypothesis Every Day Before Breakfast: It Keeps Him Young” (Konrad Lorenz, 1903–1989) 
Autophagy in liver diseases: Time for translation?
Volume 132, Issue 5, Pages (May 2007)
Ikuo Nakamura, Lewis R. Roberts  Gastroenterology 
Volume 134, Issue 1, Pages 8-14 (January 2008)
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
Clinical Gastroenterology and Hepatology
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Platelets arrive at the scene of fibrosis……studies
Controversies in Liver Transplantation for Hepatitis C
Presentation transcript:

Volume 146, Issue 5, Pages 1160-1164 (May 2014) Identifying Molecular Factors That Contribute to Resolution of Liver Fibrosis  John P. Iredale  Gastroenterology  Volume 146, Issue 5, Pages 1160-1164 (May 2014) DOI: 10.1053/j.gastro.2014.03.019 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 Dual effects of vascular endothelial growth factor (VEGF) in liver fibrogenesis and fibrosis resolution. Repeated liver injury results in hepatocellular damage (apoptosis and/or necrosis) that recruits inflammatory cells and the subsequent activation of hepatic stellate cells (HSC) mediates liver fibrosis. VEGF plays an active role in liver fibrogenesis by stimulating the synthesis of extracellular matrix proteins and favoring angiogenesis. When the cause of liver injury is removed, the liver activates mechanisms of tissue repair. Under these conditions, VEGF play an opposing role by promoting fibrosis resolution. The mechanisms include CXCL9 up-regulation and increased vascular permeability that favor the recruitment of scar tissue–associated macrophages (SAM). These events result in metalloproteinase-13 (MMP-13) up-regulation, which contributes to the degradation of extracellular matrix proteins. Regression of fibrosis is also associated by a decrease in the number of HSC owing to cell apoptosis and cell “deactivation” regaining a quiescent phenotype. Gastroenterology 2014 146, 1160-1164DOI: (10.1053/j.gastro.2014.03.019) Copyright © 2014 AGA Institute Terms and Conditions